Sunday, November 17, 2024
- 10:30AM-12:30PM
-
Abstract Number: 1611
Impact of Mepolizumab on Patient-reported Outcomes in Eosinophilic Granulomatosis with Polyangiitis by Using the ANCA-associated Vasculitis Patient-reported Outcomes (AAV-PRO) Questionnaire: A European Multicentre Prospective Study
Vasculitis – ANCA-Associated Poster II- 10:30AM-12:30PM
-
Abstract Number: 1198
Impact of Metabolic Syndrome on Knee Osteoarthritis Severity and Progression: A PROCOAC Cohort Study
Osteoarthritis – Clinical Poster I- 10:30AM-12:30PM
-
Abstract Number: 1411
Impact of Patient and Physician Alignment on Sjögren’s Disease Severity, a Real-World Survey on Patients’ Clinical Outcomes and Health-Related Quality of Life
Sjögren's Syndrome – Basic & Clinical Science Poster I- 10:30AM-12:30PM
-
Abstract Number: 1055
Impact of Provider Billing vs. Pharmacy Dispensation for Romosozumab Treatment Discontinuation Among U.S. Postmenopausal Women with Osteoporosis
Health Services Research – ACR/ARP Poster II- 10:30AM-12:30PM
-
Abstract Number: 1111
Impact of Scleroderma, Antiphospholipid Syndrome, Behçet’s Disease, and Dermatomyositis on Mortality Among Hospitalized Patients with Pulmonary Embolism
Miscellaneous Rheumatic & Inflammatory Diseases Poster II- 10:30AM-12:30PM
-
Abstract Number: 1045
Impact of Stable Rheumatologic Therapy on Outcomes of Depression in Members with Rheumatoid Arthritis, Psoriatic Arthritis, and Systemic Lupus Erythematosus
Health Services Research – ACR/ARP Poster II- 10:30AM-12:30PM
-
Abstract Number: 1522
Impact of Thrombocytopenia on In-hospital Mortality and Healthcare Resource Utilization in Patients with Systemic Lupus Erythematosus: An Analysis of the National Inpatient Sample Database 2020
SLE – Diagnosis, Manifestations, & Outcomes Poster II- 10:30AM-12:30PM
-
Abstract Number: 1047
Impact of Treatment Switching on Adherence in Members with Rheumatoid Arthritis, Psoriatic Arthritis, or Systemic Lupus Erythematosus
Health Services Research – ACR/ARP Poster II- 10:30AM-12:30PM
-
Abstract Number: 1625
Impacts of a Fast-Track Referral Clinic on Health Care Utilization, Delays and Complications in Patients with Giant Cell Arteritis
Vasculitis – Non-ANCA-Associated & Related Disorders Poster II- 10:30AM-12:30PM
-
Abstract Number: 1275
Implementing Integrated Mental Health Care in a Juvenile Myositis Clinic: A One-Year Review
Pediatric Rheumatology – Clinical Poster II- 10:30AM-12:30PM
-
Abstract Number: 1168
Improved Survival in Patients with Myositis-Associated Interstitial Lung Disease (ILD) During the Period 2011 to 2023: Comparative and Integrative Analysis of Three Multicenter Cohorts in Japan
Muscle Biology, Myositis & Myopathies – Basic & Clinical Science Poster II- 10:30AM-12:30PM
-
Abstract Number: 1543
Improvements in BILAG Musculoskeletal and Mucocutaneous Domains at Week 48 in a Phase 2 Double-Blind Placebo-Controlled Trial of ABBV-599 (Elsubrutinib + Upadacitinib Combination) and Upadacitinib Monotherapy for Treatment of Moderately to Severely Active Systemic Lupus Erythematosus
SLE – Treatment Poster II- 10:30AM-12:30PM
-
Abstract Number: 1068
Improving Health Numeracy Literacy in Pediatric Patients with SLE
Measures & Measurement of Healthcare Quality Poster- 10:30AM-12:30PM
-
Abstract Number: 1264
Improving Mental Health Care for Youth with Juvenile Dermatomyositis Through Integration of Mental Health Screening into Pediatric Rheumatology Clinic
Pediatric Rheumatology – Clinical Poster II- 10:30AM-12:30PM
-
Abstract Number: 1021
Improving Preoperative Osteoporosis Screening for Orthopedic Patients